Carisma Therapeutics Inc. buy dimontalban
Start price
21.08.21
/
30%
€17.58
Target price
21.08.22
€220.00
Performance (%)
-13.54%
End price
08.01.22
€15.20
Summary
This prediction ended on 08.01.22 with a price of €15.20. The price of Carisma Therapeutics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -13.54%. dimontalban has 30% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Carisma Therapeutics Inc. | -11.403% | -11.403% | -89.095% |
| iShares Core DAX® | 1.851% | 5.158% | 17.711% |
| iShares Nasdaq 100 | 1.573% | 2.589% | 39.053% |
| iShares Nikkei 225® | -0.412% | -2.857% | 13.501% |
| iShares S&P 500 | 1.128% | 2.485% | 29.871% |
According to dimontalban what are the pros and cons of Carisma Therapeutics Inc. for the foreseeable future?
Pros
Revenue growth >5% per year expected
Undervalued
High Investments for future growth
Very valuable balance sheet
Strong uniques
Differentiated customer and product portfolio
Sustainability is important
Stable Large shareholder and/or long term investor
Medium risks for its business
Good culture
Top 10 in its market
Well known brand
EBIT growth >5% per year expected
Innovative
Very Future proof/growth oriented business model
Cons
Probably not worthwhile Investment
Lower EBIT Margin than peer group
Very low/no dividend yield expected
negative Cash Flow expected
ROE lower than 10% per year
High challenges to pay loans and raise capital
Below average Management
Growths slower than the competition
Significant cyclical dependencies
Comments by dimontalban for this prediction
In the thread Sesen Bio Inc diskutieren
Kursziel geändert auf 11,0